Search

everythinglearnresearchcommunity

for

Search:↓

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

Chitosan-coated dutasteride nanocapsules improve hair treatment, and physical stimulation boosts effectiveness.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Promising cancer treatments were found, but the manufacturer closed.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Dutasteride for hair loss can cause skin reactions like itchy red plaques.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Dutasteride mesotherapy helps treat male hair loss but may harm sperm and sexual function.

Flutamide reduces hair growth better but has more side effects.

Finasteride improves chronic pelvic pain, saw palmetto doesn't.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

The finasteride patch effectively treats hair loss by enhancing skin absorption.